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Abstract
Background: Hepatitis E virus (HEV) is a major cause of hepatitis in developing countries and poses a threat to
public health worldwide. Tree shrew (Tupaia belangeri chinensis) is a useful animal model in studies on hepatitis
viruses, such as hepatitis B and C viruses. However, the use of this animal model for HEV research is yet to be
developed.
Methods: Tree shrews were intravenously (IV) injected with swine genotype 4 HEV or infected by contact-exposure
to IV infected tree shrews. RT-nPCR was performed to detect HEV RNA in the feces, tissues, and blood. HEV capsid
protein in the different tissues was detected by Western blot and estimated by quantitative RT-PCR. Anti-HEV
antibodies were determined by ELISA. Liver damages were evaluated by histopathologic examination and analysis
of liver-specific enzymes activities.
Results: Both negative and positive strands of HEV RNA were detected in the feces of the HEV-infected or
contact-exposed tree shrews 3–4 days post-inoculation. HEV RNA was detectable in the liver, spleen, kidneys,
and bile. Virusemia developed in all the HEV-infected tree shrews. HEV capsid protein was expressed in the
liver, spleen, and kidneys. The histological examination and analysis of liver-specific enzymes activities showed
that HEV caused acute liver lesions in the tree shrews. Meanwhile, the infected tree shrews showed positive
IgG and IgM antibodies.
Conclusions: Tree shrews are susceptible to HEV and may be useful animal models for HEV experimental
infection studies on pathogenesis or preclinical drug development.
Background
Hepatitis E virus (HEV) is the most common cause of
acute hepatitis worldwide. It infects 20 million people
and claims 70,000 lives annually [1]. HEV infection is
recognized as an emerging public health issue on a glo-
bal scale. It is thought to be a zoonotic virus, the reser-
voirs of which are domestic animals. HEV can infect
human and several animal species, such as pigs, deer,
wild boars, rats, chickens, mongooses, and rabbits [2]. It
is mainly transmitted via the fecal–oral route through
water or food contamination. Blood transfusion, vertical
transmission, and organ transplantation also transmit
HEV [3].
Molecular and biological studies on HEV are limited
because of the previous inability to propagate the virus
efficiently in vitro. Despite the recent successes in adapt-
ing HEV to grow in cell culture systems, the viral titer of
the inoculum remains limited [4]. Thus, an efficient ani-
mal model is an important tool to study HEV replication
and the mechanisms of its pathogenesis. Although HEV
infection animal models using non-human primates and
pigs have been successfully established, these animals are
large, costly, and difficult to handle. HEV has also been ef-
ficiently replicated in Balb/C nude mice [5], but such rep-
lication has not been achieved in C57BL/6 mice [6].
Tree shrew, also referred to as a Tupaia belangeri, be-
longs to the family Tupaiidae. Phylogenetically, tree
shrews are more closely related to humans than to
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rodents [7]. Moreover, tree shrews are commonly used
as animal infection models for virus research, especially
studies on hepatitis B virus (HBV) and hepatitis C virus
(HCV) [8, 9]. The course of HBV infection and the fea-
ture of HCC, which is similar to chronic HBV infection
in humans, have been successfully established in tree
shrew [9]. Similarly, the pathogenesis of HCV has been
well characterized in tree shrews, and the manifestation
of liver cirrhosis and hepatocellular carcinoma has been
confirmed [8]. However, the HEV infection of tree shrew
has not been reported yet. In the present study, tree
shrews were inoculated with swine HEV to establish a
novel infection animal model for HEV research.
Methods
Animals
The 15 tree shrews (male, four months old, 120–150 g)
used in this experiment were obtained from a population
of wild tree shrews (T. belangeri chinensis) from the De-
partment of Laboratory Animals, the Institute of Med-
ical Biology, the Chinese Academy of Medical Sciences,
and the Peking Union Medical College. The Animal
Care and Use Committee of the Kunming University of
Science and Technology approved the study protocol
and provided the guidelines for this study (2014JC004).
Prior to their inoculation with HEV, all the tree shrews
tested negative for HEV IgG and IgM antibodies and
HEV antigens in both their sera and feces.
Virus and inoculation
Swine HEV (Genotype 4, KM01 strain) was isolated from
a village of Kunming City, Yunnan Province, China [10].
The feces were suspended in phosphate-buffered saline
(PBS; pH 7.4) with 0.1 % diethyl pyrocarbonate (DEPC, to
inhibit RNase in the feces) at a proportion of 10 % (w/v).
The suspension was centrifuged at 12,000 × g for 10 min
and then filtered through 0.22 μm microfilters before
inoculation. The fecal supernatant was intravenously
injected into each tree shrew at a minimum viral count of
1 × 105 copies/mL, as calculated by the viral genomic titer
determined by real-time quantitative PCR [11].
A total of fifteen tree shrews were randomly divided
into three groups, namely, the HEV-infection group,
HEV contact-exposed group, and the control group, each
of which consisted of five tree shrews. The tree shrews
in the HEV-infected group were intravenously injected
with 0.2 ml HEV and each tree shrew housed in an indi-
vidual cage. Those in the HEV-contacted group were
not inoculated with HEV but were kept cohabiting with
one HEV-infected tree shrew. Those in the control
group were injected with PBS. The feces were collected
daily and the sera weekly from each tree shrew after in-
oculation. Each of the tree shrews was humanely eutha-
nized at 7, 14, 21, or 28 day post-inoculation (dpi)
following the guidelines of the Care and Use of Labora-
tory Animals. The liver, bile, spleen, kidneys, and colon
were collected for HEV antigen detection and stored at
−80 °C until use. The livers were fixed in 10 % neutral
buffered formalin for histopathologic examination.
Determination of HEV antibodies by ELISA
The sera were tested for the presence of HEV-specific
IgG and IgM antibodies using commercial ELISA kits
(Wantai Biological Pharmacy Co., Beijing, China), which
contained recombinant ORF2 peptides from the HEV
genome, as well as both positive and negative controls.
The sensitivity and specificity of the kits have been re-
ported for human [12], mouse [5], and rhesus macaque
[13] in previously studies. The cutoff value for the IgM
assay was determined to be 0.26 (0.16 for IgG), aside
from the mean OD450 values of the sera from the nega-
tive control (± standard deviation).
Detection of negative-strand RNA of HEV by RT-nPCR
The total RNA of the feces or tissues was extracted
using Trizol (Invitrogen, USA), in accordance with the
manufacturer’s instructions. Reverse transcription was
performed using M-MLV reverse transcriptase. Strand-
specific primers were utilized to detect both positive and
negative strands of HEV in the feces and tissues, as de-
scribed previously [14, 15]. Exactly 5 μl of cDNA was
used to separately amplify the positive or negative HEV
strands with strand-specific primers by nested PCR
(nPCR). False positive reactions for negative-strand RNA
were excluded by amplification with cDNA without
primers. The protocol was as follows: 94 °C for 2 min,
followed by 94 °C for 30 s, 42 °C for 30 s, and 72 °C for
1 min, all of which were repeated for 29 cycles. The PCR
products were detected via electrophoresis on agarose
gel containing 0.5 μg/mL ethidium bromide.
Quantitative determination of HEV by real-time qPCR
The copy number of HEV in the different organs was
analyzed using SYBR green-based qPCR assays with
HEV specific primers as described previously [11].
Briefly, the synthesized first-strand cDNA (2 μL) was
added as a template. Real-time qPCR was performed
under the following conditions: 95 °C for 30 s, followed
by 39 cycles of 95 °C for 5 s and 60 °C for 31 s. The
housekeeping gene (GAPDH) served as a loading con-
trol. Real-time qPCR was performed using an ABI
PRISM 7300 real-time PCR system. A standard curve
was generated from serial 10-fold dilutions of the syn-
thetic HEV ORF2 from 10 to 1.0 × 108 copies/mL. The
synthetic HEV ORF2 was subjected to RT and the
limited-cycle PCR step similar to that used for the RNA
extracted from the stool and sera samples.
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Detection of HEV capsid protein by Western blot
The liver, spleen, kidneys, and colon were collected at 20
dpi. The distribution of the HEV antigen (capsid protein)
in the different tissues was detected by Western blot.
The tissues were lysed in RIPA buffer (50 mM Tris,
pH 7.4, 150 mM NaCl, 5 mM EDTA, pH 8.0, 30 mM
NaF, 1 mM Na3VO4, 40 mM β-glycerophosphate,
0.1 mM PMSF, protease inhibitors, 10 % glycerol and
1 % Nonidet-P40). The equivalent amount of total pro-
tein was then separated through 10 % sodium dodecyl
sulfate–polyacrylamide gel electrophoresis and was elec-
trophoretically transferred onto a nitrocellulose mem-
brane. The non-specific-binding sites were blocked with
5 % skim milk, and the membrane was incubated with
an HEV ORF2 monoclonal antibody (Millipore,
MAB8003, 1:1000 dilutions) at 4 °C overnight. A goat–
rabbit IgG conjugated with HRP was used as secondary
antibody (Promega, America, 1:10,000 dilutions). The
GAPDH protein incubated with monoclonal antibody
(Proteintech, 1:10,000 dilutions) served as the loading
control. The bands were exposed to X-ray films using
the SuperSignal West Pico Trial Kit (Pierce, USA).
Liver biochemistry profile in the sera
The activities of alanine transaminase (ALT), aspartate
transaminase (AST), and alkaline phosphatase (ALP) in
the sera were measured with an automated biochemistry
analyzer (Olympus 2700, Japan).
Histopathologic examination
The formalin-fixed livers were processed in paraffin fol-
lowing standard protocol. They were sectioned at a
thickness of 3 μm and stained with hematoxylin and
eosin. The sections from the control group served as the
negative control. All the sections were examined using a
Nikon Ti-E microscope (Japan).
Results
HEV shedding in the feces
HEV shedding in the feces is the most important mani-
festation of HEV infection. In this study, HEV RNA was
first detected in the feces of the HEV-infected tree
shrews from 3–4 dpi. The infected tree shrews mani-
fested persistent HEV shedding until the end of the ex-
periment (28 dpi, Table 1). As expected, all the tree
shrews in the HEV contact-exposed group tested positive
for HEV RNA from 3 or 5 dpi to 28 dpi.
An intermediate negative-strand RNA is produced by
HEV when it replicates. Thus, the detection of a negative
RNA strand is indicative of HEV replication [15]. In this
work, the negative strand of HEV RNA, which was de-
tectable from 3–4 dpi to 28 dpi (end of the experiment)
in the HEV-infected and HEV contact-exposed groups
(Table 1). However, the tree shrew inoculated with PBS
tested negative for HEV RNA in the feces for the entire
duration of the experiment.
Replication of HEV in multiple organs
The liver, bile, spleen, kidney, colon, and blood of the
tree shrews were collected at 7, 14, 21 and 28 dpi, and
the total RNA was separately extracted. HEV RNA was
detected in all the organs of the tree shrews in the HEV-
infected and HEV contact-exposed groups, except for
the colon, which was washed twice with PBS to exclude
the contamination of feces (Table 1). This finding con-
firmed that, in addition to the liver, the spleen and kid-
ney are additional HEV replication sites.
A negative-strand HEV RNA was detected in the liver
and spleen samples from all the inoculated and contact-
exposed tree shrews at 28 dpi. A negative-strand RNA
was also detected in the kidney of the HEV-infected tree
shrew at 7 dpi (4/5 in the HEV-infected group and 3/5
in the HEV contact-exposed group) (Table 1). This result
indicates that HEV replicates in the kidney. Spleen is
Table 1 HEV RNA detection in tree shrews
Group Strands PBS HEV infection HEV contact
HEV RNA Feces 0d Positive +(0/5) +(0/5) +(0/5)
Negative +(0/5) +(0/5) +(0/5)
3d Positive +(0/5) +(3/5) +(0/5)
Negative +(0/5) +(3/5) +(0/5)
5d Positive +(0/5) +(5/5) +(5/5)
Negative +(0/5) +(5/5) +(5/5)
7d Positive +(0/4) +(4/4) +(4/4)
Negative +(0/4) +(4/4) +(4/4)
14d Positive +(0/3) +(3/3) +(3/3)
Negative +(0/3) +(2/3) +(3/3)
21d Positive +(0/2) +(2/2) +(2/2)
Negative +(0/2) +(2/2) +(2/2)
28d Positive +(0/1) +(1/1) +(1/1)
Negative +(0/1) +(1/1) +(1/1)
Liver Positive +(0/5) +(5/5) +(5/5)
Negative +(0/5) +(4/5) +(5/5)
Bile Positive +(0/5) +(5/5) +(5/5)
Negative +(0/5) +(3/5) +(5/5)
Spleen Positive +(0/5) +(5/5) +(5/5)
Negative +(0/5) +(5/5) +(5/5)
Kidney Positive +(0/5) +(4/5) +(3/5)
Negative +(0/5) +(4/5) +(3/5)
Colon Positive +(0/5) +(1/5) +(0/5)
Negative +(0/5) +(0/5) +(0/5)
Serum Positive +(0/5) +(5/5) +(5/5)
Negative +(0/5) +(5/5) +(5/5)
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another important HEV replication site, which tested
positive in the HEV-infected tree shrews, including
HEV-infected and HEV contact-exposed groups. The
long-term and persistent shedding of HEV may cause
splenomegaly, a major clinical feature of HEV infection.
The blood samples collected at 7, 14, 21 and 28 dpi
tested positive for HEV RNA (both positive and negative
strands), thereby suggesting the presence of HEV in the
blood circulation of the HEV-infected tree shrews for
four weeks. Moreover, the level of replication in different
tissues was estimated by qRT-PCR (Fig. 1). Results indi-
cated that the liver is the main replication site of HEV
and that the high amount of virus in the blood circula-
tion is the primary source of the infection of multiple
organs.
Distribution of HEV capsid protein in different tissues
Capsid protein was examined by Western blot to further
analyze the antigen distribution of HEV in the different
tissues at 7, 21, and 28 dpi. The HEV capsid proteins of
the HEV-infected tree shrews were detected in the liver,
spleen, and kidney of the specimens but not in the
washed colon (Fig. 2). The highest HEV content was
found in the liver, followed by the kidneys and spleen;
this finding which was consistent with the results of
HEV in the mRNA level.
Humoral response induced by HEV in tree shrews
All the HEV-infected tree shrews tested positive for
HEV IgM antibodies, which indicated the occurrence of
acute HEV infection. However, the IgM antibody in the
contact-exposed group was elevated about one week
later compared with the directly inoculated group. All
the HEV-infected tree shrews tested positive for anti-
HEV IgG antibodies at 28 dpi. A total of two of the three
tree shrews in HEV contact-exposed group tested posi-
tive for HEV IgG at 28 dpi. All the assays were
performed in triplicate, and the data were expressed as
mean values (± standard deviation). The mean values of
OD450 for the three groups were analyzed using the
SAS system software (Fig. 3).
Liver inflammation caused by HEV
HEV infection mainly causes the swelling and inflamma-
tion of the liver. To determine whether or not it can also
cause liver injury/inflammation in tree shrews, liver-
specific enzymes activities were tested. HEV infection re-
sulted in the sharp elevation of ALT and AST, whereas
no obvious change in ALP was detected.
The liver damage was evaluated by histopathologic
examination. Increased infiltrating lymphocytes and
macrophages were observed in the HEV-infected tree
shrews. Hepatic inflammation, focal hepatocelluar necro-
sis, and liver hemorrhage were observed in all the in-
fected tree shrews. No damage was observed in any of
those in the PBS inoculation control group (Fig. 4).
Discussion
Tree shrew is a novel animal model used in biology and
virology. Although wild captured tree shrews have been
spared from HEV infection [16], Asian musk shrew (sun-
cus murinus), another species of shrew, is susceptible to
rat HEV [17]. In the present study, the HEV-infected
tree shrews manifested symptoms of HEV infection
similar to HEV-infected humans. These symptoms in-
clude HEV shedding in feces (Table 1), detectable HEV
antigens in the liver and other extra-hepatic tissues
(Fig. 2), induced humoral response (Fig. 3), elevated
liver-specific enzyme activities, and aggravated liver le-
sions (Fig. 4). These manifestations strongly suggest that
tree shrews are susceptible to HEV. HEV RNA was
first detected in the feces at 3–4 dpi; this result is
consistent with that involving HEV-infected Balb/C
nude mice (4 dpi) [5], swine (3 dpi) [18], or
Fig. 1 Level of HEV replication in the different organs of tree shrew intravenously injected with swine HEV was estimated by quantitative RT-PCR
at 0 (1 tree shrew), 7 (1), 14 (1), 21 (1), and 28 (1) dpi
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cynomolgus macaques (4–6 dpi) [19]. HEV RNA also
occurred earlier in shrews than in rats inoculated
with rat HEV infectious clone (14 dpi) [20]. Similarly,
a negative HEV strand was detectable from 3–4 dpi
to 28 dpi (i.e., end of the experiment, Table 1), which
indicates that HEV RNA was shed in the feces during
at least 4 weeks. HEV usually causes self-limited dis-
eases with viral shedding in feces for 2–4 weeks [3].
HEV infection animal models showed similar syn-
dromes. Swine HEV-infected nude mice shed virus for
3 weeks [5], and the infection of rhesus macaque lasts
for 4 weeks [21]. In the present study, a large extent
of HEV replication in the liver and serum was de-
tected even at 28 dpi, suggesting that HEV replicates
last for more than 28 dpi and that the HEV infection
of tree shrews is successful.
HEV is replicated in multiple tissues, such as the
spleen and kidneys, as confirmed by the results for Balb/
C nude mice [5] and swine [22]. Similarly, HEV RNA
and capsid protein are simultaneously detected in the
liver, spleen, and kidneys of the HEV-infected tree
shrews. This result strongly indicates that the spleen and
kidney are additional extra-hepatic replication sites of
HEV, and a recent study has confirmed that the virus is
detectable in the urine of HEV-infected patients [21]. Al-
though HEV antigens have been identified in the colon
of HEV-infected Balb/C nude mice by indirect immuno-
fluorescence assay [5], HEV RNA is detected in the PBS
washed colon of only one tree shrew (1/3). Capsid pro-
tein is not found in any of the HEV-infected tree shrews
based on the results of the Western blot. Thus, the pos-
sibility of the colon being a replication site of HEV
should be further studied. HEV RNA is detected in the
bile of the HEV-infected tree shrews; this result is simi-
lar to that for HEV-infected nonhuman primates or
Fig. 2 HEV capsid protein was detected by Western blot in different tissues in tree shrews inoculated with PBS (PBS), HEV (HEV Infection) or
contact-exposed to HEV-infected tree shrews (HEV Contact) at 7 (three tree shrews), 21 (3), and 28 (3) dpi
Fig. 3 Kinetics of detection of anti-HEV IgG and IgM antibodies in
tree shrew at 0 (three tree shrews), 7 (3), 14 (3), 21 (3), and 28 (3) dpi
were tested by ELISA
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swine. Moreover, the level of ALT and AST is obviously
elevated in the HEV-infected tree shrews. More interest-
ingly, the presence of HEV antibodies (both IgM and
IgG antibodies) in the tree shrews indicates that these
animals can be successfully used as models for acute
HEV infection studies.
Tree shrews have considerable genetic homology with
both humans and primates and are therefore useful
models for viral infections, including herpes simplex
virus [23], rotavirus [24], and hepatitis viruses, such as
HBV [9] and HCV [25]. Tree shrews are especially suit-
able for hepatitis studies. For example, liver cirrhosis
and hepatocellular carcinoma have been observed in
HCV-infected tree shrews [8]. Chronic HBV infection
has also been simulated in HBV-infected tree shrews,
and the results show histopathological changes similar to
the clinical symptoms in HBV-infected humans [9, 26].
Furthermore, trees shrews are advantageous in anti-viral
drug development and preclinical studies [27]. For in-
stance, tree shrews have been successfully used to estab-
lish a fatty liver model [28]. Thus, tree shrews may be
highly suitable animal models for HEV studies.
Conclusions
Although further investigation on both swine genotype 3
and human genotype 1 HEV are needed, the experimen-
tal infection of tree shrews appears to be a promising ap-
proach to the investigation of HEV replication. Thus,
the development of tree shrews for use as animal
infection model may become a powerful tool in HEV re-
search and in preclinical studies on drug development.
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